Skip to main content

Month: December 2020

Verizon Business launches IoT Managed Services so customers can focus on growth

BASKING RIDGE, N.J., Dec. 18, 2020 (GLOBE NEWSWIRE) — Verizon Business, today announced the launch of IoT Managed Services, an offering developed to help manage the intricacies of preparing, deploying, managing, and maintaining an IoT solution for customers who may not have the necessary staff, time, knowledge, or resources.“For many companies, cellular IoT is not always something they have fully prepared for from a staffing, implementation, and maintenance standpoint,” said Steven Szabo, Verizon Business’ vice president of Internet of Things. “Through IoT Managed Services, we are bringing a dedicated team of IoT specialists and the most reliable IoT network under one roof so customers can focus on growing their business.”The offering includes a number of services to help customers jumpstart IoT deployments, including site surveys,...

Continue reading

RAYONT INC. -RAYT, REPORTS 2020 FULL YEAR FINANCIAL RESULTS

Queensland, Australia, Dec. 18, 2020 (GLOBE NEWSWIRE) — Rayont Inc. (“Rayont” or the “Company”) (OTC PINK: RAYT), a rapid growth company focused on biotechnology, education and technology industries globally, today reported financial results for the twelve-months ended September 30, 2020.2020 Business Highlights:The focus of 2020 financial year was to complete the acquisition of the cancer-treatment technology license so that the company it is able to start commercializing it within the licensed territories.  Given the life cycle of Next Generation Photo Dynamic Therapy (NGPDT) technology, the state of medical trials in territories like Australia and China and the COVID-19 pandemic, there is a need for revenue generation in the near term. Therefore, the company have decided to venture into the fast-growing remote education segment...

Continue reading

Immunicum AB (publ) Publishes Prospectus for Admission to Trading of Newly Issued Shares on Nasdaq Stockholm

Press Release18 December 2020Immunicum AB (publ) Publishes Prospectus for Admission to Trading of Newly Issued Shares on Nasdaq StockholmImmunicum AB (publ; IMMU.ST) has today published a prospectus for admission to trading of the newly issued shares on Nasdaq Stockholm due to the resolved issue in kind as consideration for the acquisition of all shares in DCprime B.V. (The “Transaction”). The prospectus has been approved and registered by Finansinspektionen (the Swedish Financial Supervisory Authority), is available on Immunicum’s website, www.immunicum.se and will also be available on Finansinspektionen’s website, www.fi.se.Publication of ProspectusThe Extraordinary General Meeting of Immunicum on 18 December 2020 resolved to approve the Board’s decision on November 18, 2020 to acquire all shares in DCprime...

Continue reading

Immunicum AB (publ) offentliggör prospekt avseende upptagande till handel av nyemitterade aktier på Nasdaq Stockholm

Pressmeddelande18 december 2020Immunicum AB (publ) offentliggör prospekt avseende upptagande till handel av nyemitterade aktier på Nasdaq StockholmImmunicum AB (publ; IMMU.ST) har idag publicerat det prospekt som upprättats inför upptagande till handel av de nyemitterade aktierna på Nasdaq Stockholm med anledning av den beslutade apportemissionen som vederlag för förvärv av samtliga aktier i DCprime B.V. (”Transaktionen”), upprättat ett prospekt Prospektet har idag godkänts och registrerats av Finansinspektionen och finns tillgängligt på Immunicums hemsida, www.immunicum.se och kommer också att göras tillgängligt på Finansinspektionens hemsida, www.fi.se.Offentliggörande av prospektExtra bolagsstämman i Immunicum den 18 december 2020 beslutade att godkänna styrelsens beslut den 18 november 2020 om att förvärva samtliga aktier i DCprime...

Continue reading

Eric Seip Joins Ingredion as Senior Vice President, Global Operations and Chief Supply Chain Officer

WESTCHESTER, Ill., Dec. 18, 2020 (GLOBE NEWSWIRE) — Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food and beverage manufacturing industry, today named Eric Seip senior vice president, global operations and chief supply chain officer. In this role, Seip will be responsible for leading global manufacturing, supply chain and procurement excellence, driving world-class safety, delivering cost savings through efficiency management, and accelerating digital transformation. Additionally, Seip will develop, implement and maintain rigorous supply chain strategies to ensure the continued identification and assimilation of innovative thinking and best practices. Seip will report directly to Jim Zallie, Ingredion’s president and chief executive officer, and will be a member of the Company’s executive...

Continue reading

Horizon Bancorp Named One of 20 “Performance Powerhouses” in National 2021 RankingBanking by Bank Director

MICHIGAN CITY, Ind., Dec. 18, 2020 (GLOBE NEWSWIRE) — (NASDAQ GS: HBNC) Horizon Bancorp, Inc. (“Horizon” or the “Company”) earned the No. 3 spot in the www.rankingbanking.com study and was the highest-scoring financial institution with less than $10 billion in assets on the publication’s list of the top 20 “performance powerhouses” in the nation, “selected based on total shareholder return generated over a 20-year period ending June 30, 2020.”Horizon was the highest-ranked Indiana-headquartered bank in the study, earning top-five scores in four categories, including those related to board strength, technology, lending and revenue. It ranked fourth for growth in loans and total revenues from December 2014 to December 2019.“We are very proud to have Bank Director recognizing our record of success, which we attribute to our focus on...

Continue reading

MTBC to Host Virtual Investor Meetings During the Week of the J.P. Morgan Healthcare Conference

SOMERSET, N.J., Dec. 18, 2020 (GLOBE NEWSWIRE) — MTBC, Inc. (Nasdaq: MTBC) (Nasdaq: MTBCP), a leading provider of cloud-based healthcare IT solutions and services, today announced management will host virtual investor meetings during and after the virtual J.P. Morgan 39th Annual Healthcare Conference in January 2021.Management will be available during the business day Eastern Time January 13-14 and January 19-20 for scheduled virtual investor meetings. To arrange a meeting, investors should contact MTBC’s IR representation, Matt Kreps at Darrow Associates, by email at mkreps@darrowir.com or by phone at +1-214-597-8200.MTBC recently announced that it expects record revenue and adjusted EBITDA results in the fourth quarter of 2020, exceeding record third quarter results. Additionally, MTBC announced that it anticipates full-year 2020...

Continue reading

Syneos Health Acquires Illingworth Research Group, a Leading Provider of Clinical Research Home Health Services

MORRISVILLE, N.C., Dec. 18, 2020 (GLOBE NEWSWIRE) — Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the acquisition of Illingworth Research Group™, a leading provider of clinical research home health services. With healthcare already becoming more local, COVID-19 has accelerated the need for in-home clinical trial services which have realized increasing demand in recent years.A pioneer in the clinical trial home health space, Illingworth Research provides in-home and on-site research nursing services for clinical trials in more than 46 countries for the biopharmaceutical and medical device industries. This includes mobile research nurse services which eliminate wasted travel time and allow patients to remain at home during challenging circumstances. With experience...

Continue reading

Sofragi : AGM du 18.12.20 à huis clos – Résultat des votes et transformation en SICAV au 01.01.2021

COMMUNIQUÉ DE PRESSEParis, le 18 décembre 2020 à 15h00Résultat des votes de l’Assemblée Générale Mixte des Actionnairesdu 18 décembre 2020La transformation en SICAV interviendra au 1er janvier 2021Jean-Claude Campana, nouveau Directeur Général à compter du 1er janvier 2021L’assemblée générale mixte des actionnaires de SOFRAGI s’est réunie le 18 décembre 2020 à 10h00 – à huis clos – au Business Center « L’Astorg », 25, rue d’Astorg à Paris (75008), sous la présidence de Monsieur Christian Dormeau, Président Directeur Général.Le taux de participation des actionnaires (votes par correspondance et procurations), exprimé en droits de vote, a été de 86,99 % (à comparer à 87,03% pour l’AGM annuelle de 2020, 88,86 % pour celle de 2019 et 89,17 % pour celle de 2018).Les actionnaires ont plébiscité les résolutions proposées par le Conseil d’administration...

Continue reading

Arco Vara AS waived the option to purchase a development project in Sofia

In November 2017, Arco Vara AS entered into an agreement for the acquisition of a development project in the suburbs of Sofia, near the village of Lozen. The first stage of the real estate acquisition transaction, with a total area of 5.3 ha, was completed in January 2018. The second stage, with a total area of 6.8 ha, was to be completed in December 2020.Due to the freezing of the first development stage and the health care crisis, Arco Vara AS decided not to increase the land bank in Bulgaria. Upon cancellation of the transaction, Arco Vara AS paid a withdrawal fee of 250,000 euros in agreement with the seller. The seller of the property has no additional claims against Arco Vara AS.“We consider it necessary to increase the growth of Arco Vara’s development volumes in Bulgaria in the long term and in a linear manner. Completing...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.